Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05340244 · ClinicalTrials.gov registry record · NA
GE CVUS Device Evaluation
A NA study, sponsored by GE Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT05340244: Completed NA study, sponsored by GE Healthcare.
NCT05340244 is a NA study that has completed, run by GE Healthcare. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05340244, a NA study, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of the study is to collect user feedback on the Vivid E95 ultrasound system and probes during clinical procedures on the device's intended population in order to optimize the device.
Primary Outcome
The primary objective of this study is to collect user feedback from the investigational ultrasound system in TTE and TEE exams in a clinical setting. User Surveys consist of Likert scales and qualitative feedback and this data will not follow a statistical analysis plan.
Interventions
- DEVICE Investigational ultrasound exam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2022-07-26 |
| Phase | NA |
What the finished NCT05340244 record still lists
NCT05340244 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Investigational ultrasound exam is the first listed.
NCT05340244 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05340244 about?
NCT05340244 is a clinical study titled "GE CVUS Device Evaluation". The purpose of the study is to collect user feedback on the Vivid E95 ultrasound system and probes during clinical procedures on the device's intended population in order to optimize the device.
What is the current status of trial NCT05340244?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2022-06-01. Estimated completion is 2022-07-26.
What interventions are being tested in trial NCT05340244?
The interventions under investigation include: Investigational ultrasound exam (DEVICE).
Who is sponsoring clinical trial NCT05340244?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05340244's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI